Navigation Links
Trends in Prescription Medication Sharing Among Reproductive-Aged Women Reported in Journal of Women's Health
Date:8/25/2008

NEW ROCHELLE, N.Y., Aug. 25 /PRNewswire/ -- Borrowing and sharing of prescription medications is a serious medical and public health concern. A survey of nearly 7,500 women of reproductive age found that this is common practice among more than one-third of this population, according to a report published online ahead of print in Journal of Women's Health, a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online at http://www.liebertonline.com/doi/pdfplus/10.1089/jwh.2007.0769

A study designed to describe patterns of prescription medication borrowing and sharing among various groups of adults revealed that women of reproductive age (18-44 years) are more likely to report this practice (36.5%) than are other aged women (19.5%). In the overall survey of more than 25,000 women and men, 28.8% of women and 26.5% of men reported ever borrowing or sharing prescription medications.

In a paper entitled "Prescription Medication Borrowing and Sharing among Women of Reproductive Age," Emily Petersen, Sonja Rasmussen, Katherine Daniel, Mahsa Yazdy, and Margaret Honein, from the Centers for Disease Control and Prevention (CDC, Atlanta, Georgia) and Oak Ridge Institute for Science & Education (Oak Ridge, Tennessee), report that allergy medications (43.8%) and pain medications (42.6%) were the types of drugs most commonly borrowed or shared by reproductive-aged women.

The authors emphasize some of the risks involved in using another person's prescription drugs, including unanticipated side effects, complications of incorrect use, drug-drug interactions, antibiotic resistance, and risk of addiction. Of great importance for reproductive-aged women is the risk of teratogenic effects on a developing embryo or fetus if the women were to become pregnant while taking the medication.

"This study confirms what many health care providers suspect," says Susan G. Kornstein, MD, Editor-in-Chief and Executive Director of the Virginia Commonwealth University Institute for Women's Health, in Richmond, VA. "It is clear that patients need to be counseled about the potential risks of sharing and borrowing medications, especially if they are women of reproductive age."

Journal of Women's Health is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. The Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Journal of Women's Health is the Official Journal of the American Medical Women's Association (AMWA; http://www.amwa-doc.org).

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research including Obesity Management, Breastfeeding Medicine, Thyroid, Metabolic Syndrome and Related Disorders, and Diabetes Technology and Therapeutics. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, books, and newsmagazines is available at http://www.liebertpub.com

Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext. 2156, vcohn@liebertpub.com


'/>"/>
SOURCE Journal of Women's Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New Research Covers Current Trends and Future Directions of the High Performing Pharmaceutical District Sales Managers
2. Analysis of cancer incidence, mortality and survival combined reveals encouraging European trends
3. New NAPHS Annual Survey Tracks Behavioral Treatment Trends
4. Video/Online Games For Health Come Of Age: Four Major Trends Now Emerging
5. Video Gaming for Health: Major New Trends to Be Discussed as National Conference Gets Underway
6. Current Trends in Arm Lift Surgery
7. New Medicare and Medicaid Data Released: Featuring Up-To-Date Enrollment Trends, State Initiatives, Regional Market Share and Prescription Drug Benefits
8. Drug use increasingly glamorized in rap music, according to new study of 2-decade trends
9. Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds
10. Employers Enjoy PBM Savings & Negative Rx Trends
11. Part-Time Practice Trends Intensify Physician Shortage According to AMGA and Cejka Search 2007 Physician Retention Survey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... How big is ... facilities, and who are the most active developers? , In the first ... Real Estate Insights (HREI) found that outpatient medical real estate development projects totaling ...
(Date:3/29/2017)... ... 29, 2017 , ... The assembly of synthetic DNA has ... repetitive steps and often scientists require many different versions of DNA. Therefore, this ... in a lower error rate and cost saving for reagents and consumables. , ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... The Wharton ... WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift to establish ... admission opportunity that will provide a pathway to a Wharton MBA for highly-qualified Penn ...
(Date:3/28/2017)... , ... March 28, 2017 , ... For many women, getting birth control isn’t as ... , meaning they either don’t have access to a health care facility or a pharmacy ... remote regions of the United States or for many who are faced with health or ...
(Date:3/28/2017)... ... 29, 2017 , ... The Thyroid Secret is a specialized ... The program was recently launched on March 1, and Dr. Wentz discussed varied ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
(Date:3/29/2017)... , March 29, 2017  Maxor National Pharmacy ... announced that it has named Leah Bailey ... all divisions of the company. With more ... the previous 8 years focused on health care, Bailey ... her tenure at Prime, Bailey advised the PBM, Specialty, ...
(Date:3/29/2017)... Varian Medical Systems (NYSE: VAR ) ... quarter of fiscal year 2017 following the close of regular ... be followed by a teleconference available to all interested parties ... to the conference call webcast will be available on the ... call and replay: ...
Breaking Medicine Technology: